Ion Peptides
50 mg vial
- Vendor score
- 78/100
- Effective vial price
- Not available
- Effective price per mg
- Not available
ORView VendorPurchase link pending destination approval.
AICAR is commonly sold or discussed for weight management, energy use, glucose control, and body composition research.
Also known as aicar
Research shortlist · Sep 12, 2026
These research selections use the same basis: 50 mg vial. The selections remain from Sep 12, 2026; each price below comes from its dated market observation.
50 mg vial
50 mg vial
What it is
AICA ribonucleotide is a 1-(phosphoribosyl)imidazolecarboxamide that is acadesine in which the hydroxy group at the 5' position has been converted to its monophosphate derivative. It has a role as a cardiovascular drug, a mouse metabolite, a Saccharomyces cerevisiae metabolite, a plant metabolite, an Escherichia coli metabolite and a human metabolite. It is an aminoimidazole and a 1-(phosphoribosyl)imidazolecarboxamide. It is functionally related to an acadesine. It is a conjugate acid of a 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-). The listed molecular formula is C9H15N4O8P. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
5 registered studies were found under this name in the current review. Each study still needs to be checked for the exact compound identity, population, endpoints, and results.
Search indexed research for this compound ↗Market context
AICAR is commonly sold or discussed for weight management, energy use, glucose control, and body composition research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Same format. Same amount.
1 of 1 formats had a qualifying research shortlist on Sep 12, 2026. Vendor counts below reflect the available price observations.
Vendor directory
Grades describe the vendor record overall. They are not a test result for every product.
| Vendor | Grade | Compared offers | In stock when checked | Lowest effective package | Profile |
|---|---|---|---|---|---|
| Core PeptidesVendor grade | Grade B+ | 1 | 0 | $6250 mg vial · compare →Observed Sep 21, 2026Out of stock when observed | View → |
| SaiyanMedVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| Ion PeptidesVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| RUOVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| Premier Bio LabsVendor grade | Grade A- | 1 | 1 | $4750 mg vial · compare →Observed Sep 21, 2026 | View → |
| Nationwide PeptidesVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| PeptidologyVendor grade | Grade C | Not available | Not available | Not availableNo market observation | View → |
| AIO PeptidesNot enough information to grade | Not enough information to grade | 1 | 1 | $43.52Automatic percent off · listed $54.4050 mg vial · compare →Observed Sep 21, 2026 | View → |
| American Peptide ResearchNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| Pharma Grade PeptidesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| Pura PeptidesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.